Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy

Infection and Immunity

Volumn 70, Issue 9, 2002, Pages 4833-4840

  Katae, Masaharu ^a   Miyahira, Yasushi ^a   Takeda, Kazuyoshi ^a   Matsuda, Hironori ^a   Yagita, Hideo ^a   Okumura, Ko ^a   Takeuchi, Tsutomu ^a   Kamiyama, Tsuneo ^a   Ohwada, Akihiko ^a   Fukuchi, Yoshinosuke ^a   Aoki, Takashi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; INTERLEUKIN 12; MEMBRANE ANTIGEN; SIALIDASE SURFACE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHAGAS DISEASE; EPITOPES; FEMALE; GENES, PROTOZOAN; GLYCOPROTEINS; IMMUNIZATION, PASSIVE; INTERLEUKIN-12; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEURAMINIDASE; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PEPTIDE FRAGMENTS; PROTOZOAN VACCINES; SPECIES SPECIFICITY; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 0036719559     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.9.4833-4840.2002     Document Type: Article

References (50)

1. The evolution of DNA vaccines
2. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
3. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T-cell activity: Implications for the age-related decline in CTL
4. Isotopes incorporated in the nucleic acids of Trypanosoma mega
5. +-T-cell responses
6. + T-cell responses against malaria liver stages
7. Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., agente etiolojico de nova entidade morbida do homem
8. Accessory molecule and costimulation requirements for CD4 T cell response
9. + T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene
10. Novel organization and sequences of five genes encoding all six enzymes for de novo pyrimidine biosynthesis in Trypanosoma crazi
11. Towards a new generation of vaccines: The cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens
12. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T-cell responses in randomly selected populations
13. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
14. DNA vaccines: Immunology, application, and optimization
15. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon
16. Vaccination for malignant melanoma: Recent developments
17. Trypanosoma species (American trypanosomiasis, Chagas disease): Biology of trypanosomes
18. American trypanosomiasis (Chagas' disease): A tropical disease now in the United States
19. Role of costimulatory molecules in autoimmunity
20. + CTL
21. Expression of a membrane-bound form of Trypanosoma cruzi trans-sialidase in baculovirus-infected insect cells: A potential tool for sialylation of glycoproteins produced in the baculovirus-insert cells system
22. Kinetoplastidae display naturally occurring ancillary DNA-containing structures
23. + T cells using an ELISPOT assay
24. + responses in mice
25. + T cell-mediated protective immunity against Trypanosoma cruzi
26. + T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques
27. + T cell responses induced by recombinant influenza and vaccinia viruses
28. Trypanosoma cruzi: Roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance
29. + T cell epitope of the CS protein of P. yoelii: Enhanced memory response by boosting with recombinant vaccinia virus
30. Cytokines and costimulatory molecules as genetic adjuvants
31. Clinical and epidemiological aspects of Chagas disease
32. MHC ligands and peptide mortifs: First listing
33. The prime-boost strategy: Exciting prospects for improved vaccination
34. Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma
35. Interleukin-12 as an adjuvant for cancer immunotherapy
36. Predominance of CD4 Th1 and CD8 Tcl cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene
37. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8
38. Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice
39. Structural and functional properties of Trypanosoma trans-sialidase
40. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
41. Genetically modified viruses: Vaccines by design
42. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi
43. Susceptibility of beta microglobulin-deficient mice to Trypanosoma cruzi infection
44. Trypanosoma cruzi infection in MHC-deficient mice: Further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease
45. In situ cancer vaccination: An IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity
46. Immunobiology of interleukin-12
47. + TC1 responses
48. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection
49. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi
50. + T cells